Recombinant STING/TMEM173 antibody (AA 190-290)
Quick Overview for Recombinant STING/TMEM173 antibody (AA 190-290) (ABIN7871636)
Target
See all STING/TMEM173 (TMEM173) AntibodiesAntibody Type
Reactivity
Host
Clonality
Conjugate
Application
Grade
Clone
-
-
Binding Specificity
- AA 190-290
-
Purpose
- MITA Antibody / Mediator of IRF3 activation / STING1 / ERIS (azide and preservative free)
-
Purification
- Protein A/G affinity
-
Immunogen
- A recombinant partial protein sequence (within amino acids 190-290) from the human protein was used as the immunogen for the MITA antibody.
-
Isotype
- IgG, kappa
-
-
-
-
Application Notes
- Optimal dilution of the MITA antibody should be determined by the researcher.
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- 1 mg/mL
-
Buffer
- 1 mg/mL in 1X PBS, BSA free, sodium azide free
-
Preservative
- Azide free
-
Storage
- -20 °C
-
Storage Comment
- Aliquot the MITA antibody and store frozen at -20oC or colder. Avoid repeated freeze-thaw cycles.
-
-
- STING/TMEM173 (TMEM173) (Transmembrane Protein 173 (TMEM173))
-
Alternative Name
- MITA
-
Background
- TMEM173 (transmembrane protein 173), also called MITA (Mediator of IRF3 activation), STING1 and ERIS, is a 379 amino acid protein encoded by a gene mapping to human chromosome 5. With 181 million base pairs encoding around 1,000 genes, chromosome 5 is about 6 % of human genomic DNA. It is associated with Cockayne syndrome through the ERCC8 gene and familial adenomatous polyposis through the adenomatous polyposis coli (APC) tumor suppressor gene. Treacher Collins syndrome is also chromosome 5 associated and is caused by insertions or deletions within the TCOF1 gene. Deletion of the p arm of chromosome 5 leads to Cri du chat syndrome. Deletion of 5q or chromosome 5 altogether is common in therapy-related acute myelogenous leukemias and myelodysplastic syndrome.
-
UniProt
- Q86WV6
-
Pathways
- Activation of Innate immune Response
Target
-